全文获取类型
收费全文 | 4866篇 |
免费 | 314篇 |
国内免费 | 145篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 28篇 |
妇产科学 | 62篇 |
基础医学 | 252篇 |
口腔科学 | 51篇 |
临床医学 | 272篇 |
内科学 | 624篇 |
皮肤病学 | 63篇 |
神经病学 | 260篇 |
特种医学 | 42篇 |
外科学 | 134篇 |
综合类 | 803篇 |
预防医学 | 234篇 |
眼科学 | 23篇 |
药学 | 2045篇 |
2篇 | |
中国医学 | 279篇 |
肿瘤学 | 126篇 |
出版年
2023年 | 59篇 |
2022年 | 99篇 |
2021年 | 125篇 |
2020年 | 117篇 |
2019年 | 120篇 |
2018年 | 133篇 |
2017年 | 167篇 |
2016年 | 178篇 |
2015年 | 183篇 |
2014年 | 337篇 |
2013年 | 398篇 |
2012年 | 280篇 |
2011年 | 386篇 |
2010年 | 239篇 |
2009年 | 236篇 |
2008年 | 219篇 |
2007年 | 214篇 |
2006年 | 187篇 |
2005年 | 171篇 |
2004年 | 127篇 |
2003年 | 131篇 |
2002年 | 93篇 |
2001年 | 82篇 |
2000年 | 73篇 |
1999年 | 62篇 |
1998年 | 59篇 |
1997年 | 46篇 |
1996年 | 69篇 |
1995年 | 55篇 |
1994年 | 49篇 |
1993年 | 54篇 |
1992年 | 51篇 |
1991年 | 66篇 |
1990年 | 56篇 |
1989年 | 52篇 |
1988年 | 42篇 |
1987年 | 37篇 |
1986年 | 33篇 |
1985年 | 42篇 |
1984年 | 35篇 |
1983年 | 25篇 |
1982年 | 30篇 |
1981年 | 15篇 |
1980年 | 19篇 |
1979年 | 8篇 |
1978年 | 11篇 |
1977年 | 10篇 |
1976年 | 14篇 |
1975年 | 7篇 |
1974年 | 7篇 |
排序方式: 共有5325条查询结果,搜索用时 31 毫秒
1.
Platelet function has been described by many laboratory assays, and PL-11 is a new point-of-care platelet function analyzer based on platelet count drop method, which counts platelet before and after the addition of agonists in the citrated whole blood samples. The present study sought to compare PL-11 with other three major more established assays, light transmission aggregometry (LTA), VerifyNow? aspirin system and thromboelastography (TEG), for monitoring the short-term aspirin responses in healthy individuals. Ten healthy young men took 100?mg/d aspirin for 3-day treatment. Platelet function was measured via PL-11, LTA, VerifyNow and TEG, respectively. The blood samples were collected at baseline, 2 hour, 1 day during the aspirin treatment and 1 day, 5?±?1 days, 8?±?1 days after the aspirin withdrawal. Moreover, 90 additional healthy subjects were recruited to establish a reference range for PL-11. Platelet function of healthy subjects decreased significantly 2 hours after 100?mg/d aspirin intake and began to recover during 4–6 days after the aspirin withdrawal. Correlations between methods were PL-11 vs. LTA (r?=?0.614, p?<?0.01); PL-11 vs. VerifyNow (r?=?0.829, p?<?0.01); PL-11 vs. TEG (r?=?0.697, p?<?0.001). There was no significant bias between PL-11 and LTA at baseline (bias?=?1.94%, p?=?0.804) using Bland-Altman analysis, while the data of PL-11 were significantly higher than LTA (bias?=?24.02%, p?<?0.001) during the aspirin therapy. The reference range for PL-11 in healthy young individuals was from 66.8 to 90.5% (95%CI). When aspirin low-responsiveness was defined as LTA?>?20%, the cut-off values for each method were, respectively: PL-11?>?50%, VerifyNow?>?533 ARU, TEG?>?60.2%. The results of different platelet function assays were uninterchangeable for monitoring aspirin response and correlations among them were also varied. Correlations among PL-11 and other three major assays suggested the ability of PL-11 to assess the treatment effects of aspirin. But a large cohort study is needed to confirm the cut-off value of aspirin response detected by PL-11. 相似文献
2.
1-乙基-6-氟-1,4-二氢-4-氧代-7-(4-芳酰硫代氨甲酰基-1-哌嗪基)-3-喹啉羧酸的合成及抗菌作用 总被引:4,自引:1,他引:3
Thirteen new 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-aroyl-thiocarbamoyl- 1 piperazinyl)-3-quinoline carboxylic acids were prepared, Their structures were characterized by elemental analysis, IR, HNMR and MS spectra.Preliminary pharmacological tests indicated that some of compounds Ia~m possess strong inhibiting activity against Escherichia coli, Bacillus subtilis and Proteus at concentration of 100 μg/ml. 相似文献
3.
4.
目的探讨小剂量阿司匹林与银可络联用对老年患者血液流变学异常的影响。方法57例老年病人并伴有高凝、高粘血症者采用小剂量阿司匹林50mg,口服,1次/d,银可络80mg,口服,3次/d。疗程为1个月。并测定治疗前后血液流变学各项参数。结果病例组治疗后血小板粘附率(PadT)、血栓长度、重量与对照组比较均有显著性差异(P均<0.01);治疗后红细胞刚性指数(IR)、血沉(ESR)、红细胞电泳时间(EFT)、全血表现粘度(BAV)与治疗前比较均有显著性差异(P均<0.001);病例组治疗后红细胞比积(HCT)、纤维蛋白原(Fib)、血浆比粘度(PV)与对照组比较均无显著性差异(P均>0.05)。结论小剂量阿司匹林与银可络联合治疗对血栓形成过程有抑制作用,红细胞变形能力和聚集性有所改善。但对Fib,PV,HCT无影响。 相似文献
5.
MP Costi D Tondi M Rinaldi D Barlocco G Cignarella DV Santi C Musiu I Pudu G Vacca P La Colla 《European journal of medicinal chemistry》1996,31(12):1011-1016
A new series of N-(substituted)benzyl-1,8-naphthalimides 4, structurally related to the previously reported thymidylate synthase (TS) inhibitor naphthaleins 3, were synthesized and compounds tested for their inhibition of several species of TS. Moreover, their in vitro cytotoxicity together with antimycotic and antibacterial properties were assayed. While no activity was detected in the antibacterial tests, the m-nitro (4ae) and the p-nitro (4af) derivatives were found able to partially inhibit TS at low micromolar concentrations. Introduction of nitro or (substituted)-amino groups in position 4 of the naphthalic ring always led to less active compounds. 相似文献
6.
7.
阿司匹林间歇疗法在脑卒中二级预防中的临床价值 总被引:5,自引:0,他引:5
目的观察阿司匹林间歇疗法与常规疗法在脑卒中二级预防中临床价值的差异。方法收集250例脑卒中恢复期患者,按随机单盲开放对照原则分为间歇疗法组(间歇组)(每8周内停药1周)和常规疗法组(单规组)各125例,均给予阿司匹林100mg Qd治疗2年。结果(1)2组脑卒中再发率无明显差异;(2)2组患者的血小板聚集率和凝血功能无明显差异;(3)间歇组上消化道出血、腹痛、腹泻等不良反应发生率较常规组明显下降(P<0.01)。结论阿司匹林间歇疗法较常规疗法能有效减低了长期治疗导致的消化道不良反应,同时有效降低脑卒中的再发率,在脑卒中二级预防中具有重要的临床应用价值。 相似文献
8.
低剂量阿司匹林在辅助生育技术中的应用 总被引:2,自引:0,他引:2
目的 探讨在进行体外受精 -胚胎移植 ( IVF-ET)或卵母细胞浆内单精子注射 ( ICSI)患者口服低剂量阿司匹林对治疗结果的影响。 方法 IVF或 ICSI治疗的 3 2 4个 ET周期 ,分为是否服用阿司匹林两组 ,分别统计患者注射人绒毛膜促性腺激素 ( h CG)时子宫内膜厚度及 ET胚胎数 ,比较两组的胚胎种植率、临床妊娠率及流产率 ,并进行统计学处理。 结果 两组在注射 h CG日内膜平均厚度、ET中优质胚胎的比率及流产率均无显著性差异 ;未服用阿司匹林组的 ET胚胎数明显多于服用组 ( P<0 .0 1 ) ,而前者的种植率、临床妊娠率却明显低于后者 ( P<0 .0 1 )。 结论 低剂量阿司匹林在 IVF-ET或ICSI的辅助生殖治疗中能有效地提高胚胎种植率 ,增加患者的临床妊娠率 相似文献
9.
10.
When considering the chances of establishing a healthy ongoing pregnancy after in vitro fertilization (IVF), the cause of infertility plays a relatively minor role. In recent years, there has been a shift from determining the diagnosis to the individual prognosis for a given patient. A number of prognostic factors were identified, which enabled clinicians to appropriately counsel patients. Patient-determined factors are of crucial importance and some are amenable to intervention such as lifestyle and nutritional advice. However, the attention of clinicians remains on seeking adjuvant therapeutic interventions designed to improve the outcomes of IVF treatment. In this article, the patient-determined factors underlying the individual chance of conceiving and the more commonly prescribed empirical medical therapies prescribed to enhance outcomes are reviewed. It is concluded that greater attention to optimizing the health of the couple before starting IVF treatment may be more beneficial than adjuvant medical therapies during treatment. 相似文献